PTGS2 and neoplasm: In colorectal MC38 and CT26 and breast 4T1 cells, ablation of the COX-2/PGE2 pathway significantly impaired tumor growth selectively in immunocompetent hosts (Figures S2A and S2B; Zelenay et al., 2015).